Reddit
Email
Reprint
Trade-Ideas LLC identified WebMD Health ( WBMD) as a strong on high relative volume candidate. In addition to specific proprietary factors, Trade-Ideas identified WebMD Health as such a stock due to the following factors:
WBMD has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $36.6 million.
WBMD has traded 288,520 shares today.
WBMD is trading at 12.95 times the normal volume for the stock at this time of day.
WBMD is trading at a new high 5.03% above yesterday's close.
'Strong on High Relative Volume' stocks are worth watching because major volume moves tend to indicate underlying activity such as M&A events, material stock news, analyst upgrades, insider buying, buying from 'superinvestors,' or that hedge funds and momentum traders are piling into a stock ahead of a catalyst. Regardless of the impetus behind the price and volume action, when a stock moves with strength and volume it can indicate the start of a new trend on which early investors can capitalize. In the event of a well-timed trading opportunity, combining technical indicators with fundamental trends and a disciplined trading methodology should help you take the first steps towards investment success. EXCLUSIVE OFFER: Get the inside scoop on opportunities in WBMD with the Ticky from Trade-Ideas. See the FREE profile for WBMD NOW at Trade-Ideas More details on WBMD: WebMD Health Corp. provides health information services to consumers, physicians and other healthcare professionals, employers, and health plans through its public and private online portals, mobile platforms, and health-focused publications in the United States. WBMD has a PE ratio of 38. Currently there are 8 analysts that rate WebMD Health a buy, no analysts rate it a sell, and 1 rates it a hold. The average volume for WebMD Health has been 374,400 shares per day over the past 30 days. WebMD Health has a market cap of $1.8 billion and is part of the technology sector and computer software & services industry. The stock has a beta of 0.78 and a short float of 14.2% with 6.42 days to cover. Shares are up 3.8% year-to-date as of the close of trading on Thursday. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE. TheStreetRatings.com Analysis: TheStreet Quant Ratings rates WebMD Health as a buy. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, revenue growth, expanding profit margins and solid stock price performance. We feel its strengths outweigh the fact that the company shows weak operating cash flow. Highlights from the ratings report include:
WEBMD HEALTH CORP has improved earnings per share by 39.1% in the most recent quarter compared to the same quarter a year ago. The company has demonstrated a pattern of positive earnings per share growth over the past two years. We feel that this trend should continue. During the past fiscal year, WEBMD HEALTH CORP increased its bottom line by earning $0.97 versus $0.33 in the prior year. This year, the market expects an improvement in earnings ($1.44 versus $0.97).
The net income growth from the same quarter one year ago has greatly exceeded that of the S&P 500, but is less than that of the Internet Software & Services industry average. The net income increased by 34.5% when compared to the same quarter one year prior, rising from $9.81 million to $13.19 million.
Despite its growing revenue, the company underperformed as compared with the industry average of 15.1%. Since the same quarter one year prior, revenues slightly increased by 6.3%. This growth in revenue appears to have trickled down to the company's bottom line, improving the earnings per share.
The gross profit margin for WEBMD HEALTH CORP is rather high; currently it is at 60.98%. It has increased from the same quarter the previous year. Despite the strong results of the gross profit margin, WBMD's net profit margin of 8.64% significantly trails the industry average.
Looking at where the stock is today compared to one year ago, we find that it is not only higher, but it has also clearly outperformed the rise in the S&P 500 over the same period. Although other factors naturally played a role, the company's strong earnings growth was key. Looking ahead, the stock's rise over the last year has already helped drive it to a level which is relatively expensive compared to the rest of its industry. We feel, however, that the other strengths this company displays justify these higher price levels.
You can view the full WebMD Health Ratings Report.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE. Check Out Our Best Services for Investors Action Alerts PLUS
Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.
Product Features:
$2.5+ million portfolio
Large-cap and dividend focus
Intraday trade alerts from Cramer
Quant Ratings
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
Product Features:
Buy, hold, or sell recommendations for over 4,300 stocks
Unlimited research reports on your favorite stocks
A custom stock screener
Stocks Under $10
David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.
Product Features:
Model portfolio
Stocks trading below $10
Intraday trade alerts
14-Days Free Only $9.95 14-Days Free Dividend Stock Advisor
David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
Diversified model portfolio of dividend stocks
Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks
Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.
Product Features:
Model Portfolio
Intra Day Trade alerts
Access to Quant Ratings
Real Money
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.
Product Features:
Access to Jim Cramer's daily blog
Intraday commentary and news
Real-time trading forums
Only $49.95 14-Days Free 14-Days Free View other subscription services that we offer
No comments: